These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 17695414)

  • 1. Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.
    Magri V; Trinchieri A; Montanari E; Del Nero A; Mangiarotti B; Zirpoli P; de Eguileor M; Marras E; Ceriani I; Vral A; Perletti G
    Arch Ital Urol Androl; 2007 Jun; 79(2):84-92. PubMed ID: 17695414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome.
    Magri V; Trinchieri A; Ceriani I; Marras E; Perletti G
    Arch Ital Urol Androl; 2007 Jun; 79(2):93-8. PubMed ID: 17695415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
    Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
    Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients.
    Magri V; Marras E; Restelli A; Wagenlehner FM; Perletti G
    Exp Ther Med; 2015 Mar; 9(3):658-666. PubMed ID: 25667610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidisciplinary approach to prostatitis.
    Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
    Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
    Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
    Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial therapy for asymptomatic patients with elevated prostate-specific antigen: can the change in prostate-specific antigen reliably guide prostate biopsy decisions?
    Torky M; Mosharafa A; Emran A; Kamal A; Abdelhamid M
    Urol Int; 2011; 87(4):416-9. PubMed ID: 21934292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10 ng/mL?
    Busato WF; Almeida GL; Geraldo J; Busato FS
    Int Braz J Urol; 2015; 41(2):329-36. PubMed ID: 26005976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
    Mehik A; Alas P; Nickel JC; Sarpola A; Helström PJ
    Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Asymptomatic prostatitis: a frequent cause of raising PSA].
    Terrone C; Poggio M; Bollito E; Cracco CM; Scarpa RM
    Recenti Prog Med; 2005; 96(7-8):365-9. PubMed ID: 16209120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
    Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
    Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
    Schaeffer AJ; Wu SC; Tennenberg AM; Kahn JB
    J Urol; 2005 Jul; 174(1):161-4. PubMed ID: 15947609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Serenoa repens, selenium and lycopene (Profluss®) on chronic inflammation associated with benign prostatic hyperplasia: results of "FLOG" (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study.
    Morgia G; Cimino S; Favilla V; Russo GI; Squadrito F; Mucciardi G; Masieri L; Minutoli L; Grosso G; Castelli T
    Int Braz J Urol; 2013; 39(2):214-21. PubMed ID: 23683667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patients.
    Serretta V; Catanese A; Daricello G; Liotta R; Allegro R; Martorana A; Aragona F; Melloni D
    Prostate Cancer Prostatic Dis; 2008; 11(2):148-52. PubMed ID: 17637759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/ml.
    Kaygisiz O; Uğurlu O; Koşan M; Inal G; Oztürk B; Cetinkaya M
    Prostate Cancer Prostatic Dis; 2006; 9(3):235-8. PubMed ID: 16718277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of NIH-IV prostatitis on free and free-to-total PSA.
    Stancik I; Lüftenegger W; Klimpfinger M; Müller MM; Hoeltl W
    Eur Urol; 2004 Dec; 46(6):760-4. PubMed ID: 15548444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do changes in a high serum prostate-specific antigen level and the free/total prostate-specific antigen ratio after antibiotic treatment rule out biopsy and the suspicion of cancer?
    Dirim A; Tekin MI; Koyluoglu E; Oguzulgen AI; Peskircioglu L; Ozkardes H
    Urol Int; 2009; 82(3):266-9. PubMed ID: 19440011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the effect of antibiotherapy and anti-inflammatory therapy on serum PSA levels discriminate between benign and malign prostatic pathologies?
    Erol H; Beder N; Calişkan T; Dündar M; Unsal A; Culhaci N
    Urol Int; 2006; 76(1):20-6. PubMed ID: 16401916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome.
    Nadler RB; Collins MM; Propert KJ; Mikolajczyk SD; Knauss JS; Landis JR; Fowler JE; Schaeffer AJ; Alexander RB;
    Urology; 2006 Feb; 67(2):337-42. PubMed ID: 16442595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of antibiotics on elevated serum prostate specific antigen in patients with urinary symptoms and negative digital rectal examination: a pilot study.
    Bulbul MA; Wazzan W; Hijaz A; Shaar A
    J Med Liban; 2002; 50(1-2):23-5. PubMed ID: 12841309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.